{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:42:29Z","timestamp":1783597349284,"version":"3.55.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["B2023012"],"award-info":[{"award-number":["B2023012"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2020YFC2004705"],"award-info":[{"award-number":["2020YFC2004705"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81825003"],"award-info":[{"award-number":["81825003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270376"],"award-info":[{"award-number":["82270376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-5\u2013003"],"award-info":[{"award-number":["2021-I2M-5\u2013003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Liver fibrosis was associated with adverse outcomes in various cardiovascular diseases. The current risk stratification of non-ischemic dilated cardiomyopathy (NIDCM) still largely depends on the left ventricular ejection fraction (LVEF). At present, the relationship between liver fibrosis and prognosis in patients with NIDCM remains blank.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>A total of 433 NIDCM patients were analysed in this study. Liver fibrosis was assessed by three liver fibrosis scores (LFS), including aspartate aminotransferase to platelet ratio index (APRI), aspartate aminotransferase\/alanine aminotransferase ratio (AST\/ALT ratio), and gamma-glutamyltransferase to platelet ratio (GPR). The primary endpoint was defined as all-cause mortality or heart transplantation (ACM\/HTx). During a median follow-up period of 1.7 years, 140 ACM\/HTx events occurred. Positive associations were observed between LFS and ACM\/HTx. Patients with elevated APRI, AST\/ALT ratio, and GPR scores exhibited increased ACM\/HTx (all P &amp;lt; 0.05). Intermediate-to-high APRI [hazard ratio (HR) 1.66, 95%CI 1.06\u20132.61, P = 0.027], AST\/ALT ratio (HR 1.59, 95%CI 1.07\u20132.36, P = 0.021), and GPR (HR 1.64, 95%CI 1.11\u20132.42, P = 0.013) were independently associated with increased risk of ACM\/HTx, even after adjusting for LVEF and other covariates. The positive relationship remains consistent across different subgroups, including those with diabetes and obesity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Elevated liver fibrosis scores were associated with a worse outcome beyond LVEF in patients with NIDCM, which may provide additional prognostic value in the management of NIDCM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjopen\/oead082","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T01:06:00Z","timestamp":1693011960000},"source":"Crossref","is-referenced-by-count":7,"title":["Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy"],"prefix":"10.1093","volume":"3","author":[{"given":"Yupeng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University , Guangzhou , China"},{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Song","sequence":"additional","affiliation":[{"name":"Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University , Beijing, China"},{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital , 49 North Garden Rd., Haidian District, Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Da","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital , 49 North Garden Rd., Haidian District, Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"2023092519071900600_oead082-B1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2023092519071900600_oead082-B2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"N Engl J Med"},{"key":"2023092519071900600_oead082-B3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"2023092519071900600_oead082-B4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N Engl J Med"},{"key":"2023092519071900600_oead082-B5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.cgh.2017.12.048","article-title":"High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study","volume":"16","author":"Caballer\u00eda","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2023092519071900600_oead082-B6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ehf2.13250","article-title":"Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT","volume":"8","author":"Peters","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2023092519071900600_oead082-B7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pcad.2020.02.010","article-title":"FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C","volume":"63","author":"So-Armah","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"2023092519071900600_oead082-B8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2023092519071900600_oead082-B9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","article-title":"Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease","volume":"299","author":"Chen","year":"2020","journal-title":"Atherosclerosis"},{"key":"2023092519071900600_oead082-B10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12072-021-10167-w","article-title":"Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease","volume":"15","author":"Jin","year":"2021","journal-title":"Hepatol Int"},{"key":"2023092519071900600_oead082-B11","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J"},{"key":"2023092519071900600_oead082-B12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"2023092519071900600_oead082-B13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"2023092519071900600_oead082-B14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"key":"2023092519071900600_oead082-B15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","article-title":"AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection","volume":"93","author":"Sheth","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"2023092519071900600_oead082-B16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ejhf.16","article-title":"Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years: prognosis of idiopathic dilated cardiomyopathy","volume":"16","author":"Merlo","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2023092519071900600_oead082-B17","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/hep.28390","article-title":"Noninvasive fatty liver markers predict liver disease mortality in the U.S. Population: unalp-Arida and ruhl","volume":"63","author":"Unalp-Arida","year":"2016","journal-title":"Hepatology"},{"key":"2023092519071900600_oead082-B18","doi-asserted-by":"crossref","first-page":"11957","DOI":"10.1038\/s41598-021-91368-z","article-title":"Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure","volume":"11","author":"Maeda","year":"2021","journal-title":"Sci Rep"},{"key":"2023092519071900600_oead082-B19","first-page":"32","article-title":"Liver stiffness and arterial stiffness\/abnormal central hemodynamics in the early stage of heart failure","volume":"20","author":"Iwasaki","year":"2018","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2023092519071900600_oead082-B20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00380-017-1113-1","article-title":"The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure","volume":"33","author":"Takahashi","year":"2018","journal-title":"Heart Vessels"},{"key":"2023092519071900600_oead082-B21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11897-014-0206-8","article-title":"Cardiohepatic syndrome: liver injury in decompensated heart failure","volume":"11","author":"Laribi","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"2023092519071900600_oead082-B22","doi-asserted-by":"crossref","first-page":"17562864211037239","DOI":"10.1177\/17562864211037239","article-title":"Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke","volume":"14","author":"Fandler-H\u00f6fler","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"2023092519071900600_oead082-B23","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/modpathol.2015.40","article-title":"The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation","volume":"28","author":"Louie","year":"2015","journal-title":"Mod Pathol"},{"key":"2023092519071900600_oead082-B24","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications","volume":"61","author":"Samsky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023092519071900600_oead082-B25","first-page":"111","article-title":"Heart diseases affecting the liver and liver diseases affecting the heart","volume":"140;","author":"Je N","year":"2000","journal-title":"Am Heart J"},{"key":"2023092519071900600_oead082-B26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000441-197303000-00001","article-title":"The liver in congestive heart failure: a review","volume":"265","author":"Dunn","year":"1973","journal-title":"Am J Med Sci"},{"key":"2023092519071900600_oead082-B27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2023092519071900600_oead082-B28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/17474124.2021.1842732","article-title":"Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma","volume":"15","author":"Li","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/advance-article-pdf\/doi\/10.1093\/ehjopen\/oead082\/51267656\/oead082.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/3\/5\/oead082\/51752432\/oead082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/3\/5\/oead082\/51752432\/oead082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T19:07:58Z","timestamp":1695668878000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oead082\/7251459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oead082","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,8,25]]},"article-number":"oead082"}}